ACADL and fatty liver disease: Interestingly, mice that are genetically defective in PPARα and long-chain acyl-CoA dehydrogenase exhibit decreased hepatic fatty acid oxidation and have a tendency to hepatic steatosis and insulin resistance [15,16].